Spreadex Market Update

FTSE weathers stormy Monday, Dow Jones set to drop 250 points



There was little change as Monday went on, the European indices still struggling under the threat of an escalation in tensions between the US and China, but with the FTSE remaining as an outlier.

While its peers suffered heavy losses – the DAX was down 3.4%, with the CAC down 3.9% – the FTSE managed to keep its own decline at a negligible 0.25%. A 1.8% rise from Royal Dutch Shell certainly helped, as did cable’s 0.4% fall. There was further support from Big Pharma, as AstraZeneca and GlaxoSmithKline rose around 2.5% apiece, while Ocado continued to benefit from its stay at a home demand with a 4% increase.

The UK index may find its steady performance challenged, however, when the Dow Jones et al get involved. The Dow is facing a 250 point fall once trading gets underway stateside, a drop that would push the index back below 23500, around 1400 points off of the intraday highs struck on the final day of April.

Investors are expressing their deep unease about the way Donald Trump and his most loyal colleagues are conducting themselves, stoking the fires of anti-China sentiment with threats of tariffs and conspiracies surrounding the origins of the coronavirus outbreak. Not only is this a worry now, if this is the tack used for the entirety of Trump’s 2020 presidential campaign, then US-China relations could completely disintegrate come November.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.